جزییات کتاب
Written with the practicing medicinal chemist in mind, this is the first modern handbook to systematically address the topic of bioisosterism. As such, it provides a ready reference on the principles and methods of bioisosteric replacement as a key tool in preclinical drug development. The first part provides an overview of bioisosterism, classical bioisosteres and typical molecular interactions that need to be considered, while the second part describes a number of molecular databases as sources of bioisosteric identification and rationalization. The third part covers the four key methodologies for bioisostere identification and replacement: physicochemical properties, topology, shape, and overlays of protein-ligand crystal structures. In the final part, several real-world examples of bioisosterism in drug discovery projects are discussed. With its detailed descriptions of databases, methods and real-life case studies, this is tailor-made for busy industrial researchers with little time for reading, while remaining easily accessible to novice drug developers due to its systematic structure and introductory section.Content: Chapter 1 Bioisosterism in Medicinal Chemistry (pages 1–14): Dr. Nathan BrownChapter 2 Classical Bioisosteres (pages 15–29): Caterina Barillari and Dr. Nathan BrownChapter 3 Consequences of Bioisosteric Replacement (pages 31–51): Dennis A. Smith and David S. MillanChapter 4 Bioster: A Database of Bioisosteres and Bioanalogues (pages 53–74): Istvan Ujvary and Julian HaywardChapter 5 Mining the Cambridge Structural Database for Bioisosteres (pages 75–101): Colin R. Groom, Tjelvar S. G. Olsson, John W. Liebeschuetz, David A. Bardwell, Ian J. Bruno and Frank H. AllenChapter 6 Mining for Context?Sensitive Bioisosteric Replacements in Large Chemical Databases (pages 103–127): George Papadatos, Michael J. Bodkin, Valerie J. Gillet and Peter WillettChapter 7 Physicochemical Properties (pages 129–139): Peter ErtlChapter 8 Molecular Topology (pages 141–153): Dr. Nathan BrownChapter 9 Molecular Shape (pages 155–166): Pedro J. Ballester and Dr. Nathan BrownChapter 10 Protein Structure (pages 167–181): James E. J. MillsChapter 11 The Drug Guru Project (pages 183–198): Kent D. Stewart, Jason Shanley, Karam B. Alsayyed Ahmed and J. Phillip BowenChapter 12 Bioisosteres of an NPY?Y5 Antagonist (pages 199–215): Nicholas P. Barton and Benjamin R. BellenieChapter 13 Perspectives from Medicinal Chemistry (pages 217–230): Nicholas A. Meanwell, Marcus Gastreich, Matthias Rarey, Mike Devereux, Paul L. A. Popelier, Gisbert Schneider and Peter Willett